Your browser doesn't support javascript.
loading
Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society.
Friedman, Allon N; Schauer, Philip R; Beddhu, Srinivasan; Kramer, Holly; le Roux, Carel W; Purnell, Jonathan Q; Sunwold, Duane; Tuttle, Katherine R; Jastreboff, Ania M; Kaplan, Lee M.
Affiliation
  • Friedman AN; Division of Nephrology, School of Medicine, Indiana University Indianapolis, Indiana, USA.
  • Schauer PR; Pennington Biomedical Research Institute, Louisiana State University, Baton Rouge, Louisiana, USA.
  • Beddhu S; Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Kramer H; Department of Public Health Sciences and Medicine, Loyola University Chicago, Maywood, Illinois, USA.
  • le Roux CW; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.
  • Purnell JQ; Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University, Oregon, Portland, USA.
  • Sunwold D; Culinary Program, Spokane Community College, Spokane, Washington, USA.
  • Tuttle KR; Providence Health Care and School of Medicine, University of Washington, Spokane, Washington, USA.
  • Jastreboff AM; Endocrinology & Metabolism, Department of Medicine and Pediatric Endocrinology, Department of Pediatrics, School of Medicine, Yale University, New Haven, Connecticut, USA.
  • Kaplan LM; Obesity, Metabolism, and Nutrition Institute and Gastroenterology Division, Massachusetts General Hospital, and Medical School, Harvard University, Boston, Massachusetts, USA.
Obesity (Silver Spring) ; 30(12): 2340-2350, 2022 12.
Article in En | MEDLINE | ID: mdl-36268562
ABSTRACT
The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a multispecialty international workshop in April 2021 to advance the understanding and management of obesity in adults with chronic kidney disease (CKD). The underlying rationale for the workshop was the accumulating evidence that obesity is a major contributor to CKD and adverse outcomes in individuals with CKD, and that effective treatment of obesity, including lifestyle intervention, weight loss medications, and metabolic surgery, can have beneficial effects. The attendees included a range of experts in the areas of kidney disease, obesity medicine, endocrinology, diabetes, bariatric/metabolic surgery, endoscopy, transplant surgery, and nutrition, as well as patients with obesity and CKD. The group identified strategies to increase patient and provider engagement in obesity management, outlined a collaborative action plan to engage nephrologists and obesity medicine experts in obesity management, and identified research opportunities to address gaps in knowledge about the interaction between obesity and kidney disease. The workshop's conclusions help lay the groundwork for development of an effective, scientifically based, and multidisciplinary approach to the management of obesity in people with CKD.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Renal Insufficiency, Chronic / Bariatric Surgery Limits: Adult / Humans Language: En Journal: Obesity (Silver Spring) Journal subject: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Renal Insufficiency, Chronic / Bariatric Surgery Limits: Adult / Humans Language: En Journal: Obesity (Silver Spring) Journal subject: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Year: 2022 Document type: Article Affiliation country: